OrsoBio
Latest round
- Series B
Last raised
- Aug 2024
Total raised
- $125M
Investors
- 9
About OrsoBio
Founded in 2021 and based in California, US, OrsoBio, Inc. is a biopharmaceutical company that develops therapies to treat severe metabolic disorders. As of 2023, the company is headed by its CEO Mani Subramanian, who founded the firm. In August 2024, OrsoBio, Inc. The company develops treatments for individuals suffering from severe metabolic conditions, such as type 2 diabetes, severe dyslipidemias, lipodystrophies, nonalcoholic steatohepatitis, and more. The firm therapies restore energy homeostasis that helps in the treatment of severe metabolic disorders.
Who invested in OrsoBio
9 investors across 2 rounds
See all investors in OrsoBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OrsoBio
Who invested in OrsoBio?
OrsoBio has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OrsoBio raised?
OrsoBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did OrsoBio last raise money?
OrsoBio's most recent round on record is a Series B, in Aug 2024.
What does OrsoBio do?
Founded in 2021 and based in California, US, OrsoBio, Inc.
Where is OrsoBio headquartered?
OrsoBio is headquartered in Palo Alto, US.
Which VCs invest in companies like OrsoBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OrsoBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like OrsoBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.